跳至主要内容
临床试验/ISRCTN42195152
ISRCTN42195152已完成未知

Defibrillator After Primary Angioplasty randomised trial

Individual Sponsor (Netherlands)0 个研究点目标入组 266 人开始时间: 2005年9月12日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
266

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. ST-elevation myocardial infarction treated with primary PCI within 30 days and 60 days before randomisation
  • 2. At least one of the following criteria:
  • a. Thrombolysis In Myocardial Infarction (TIMI) flow after primary PCI less than three in the infarct related vessel
  • b. Left ventricular ejection lower than 30% as measured within four days after admission

排除标准

  • 1. Class I indication for ICD implantation
  • 2. Documented previous myocardial infarction with Left Ventricular Ejection Fraction (LVEF) less than 30%
  • 3. Age less than 18 years
  • 4. Heart failure with New York Heart Association functional class IV
  • 5. Inotropic medication within two weeks before randomisation
  • 6. Mechanical tricuspid valve
  • 7. Serious comorbidity such as cancer, with a high likelihood of death during the trial
  • 8. Advanced cerebrovascular disease
  • 9. Unwilling or unable to sign the consent form for participation
  • 10. Females of childbearing age not using medically prescribed contraceptives

研究者

发起方
Individual Sponsor (Netherlands)

相似试验